Get the Stockscreener App
2.71
3.90%
-0.11
Biovie Inc Stock (BIVI) Latest News
Biovie Inc. to Present Design of Planned Phase 2 Study of Bezisterim for the Treatment of Long Covid At Theemystifying Long Covid International Conference - Marketscreener.com
BioVie to Present Design of Planned Phase 2 Study of Bezisterim for the Treatment of Long COVID at the Demystifying Long COVID International Conference - The Manila Times
BioVie to Present Design of Planned Phase 2 Study of - GlobeNewswire
BioVie's Long COVID Drug Trial Gets Pentagon Backing; Phase 2 Study to Include 200 Patients | BIVI Stock News - StockTitan
BioVie shareholders approve board nominees and equity plan expansion By Investing.com - Investing.com Canada
BioVie shareholders approve board nominees and equity plan expansion - Investing.com India
BioVie’s Upcoming Parkinson’s Disease Clinical Trial is Fully Funded - GlobeNewswire
BioVie's Upcoming Parkinson's Disease Clinical Trial is Fully Funded - The Manila Times
BioVie Raises Capital Through Direct Stock Offering - MSN
BioVie Inc. Announces Closing of Registered Direct Offering - GlobeNewswire
BioVie Raises $3.24 Million in Direct Offering - TipRanks
BioVie sets price for $3.2 million stock offering By Investing.com - Investing.com Australia
BioVie prices stock offering at $2.83 per share By Investing.com - Investing.com Canada
BIVIBioVie, Inc. Latest Stock News & Market Updates - StockTitan
BioVie prices stock offering at $2.83 per share - Investing.com
UPDATE -- BioVie Inc. Announces Pricing of Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - The Manila Times
BioVie sets price for $3.2 million stock offering - Investing.com India
BioVie Inc. Announces Pricing of Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - The Manila Times
Short Interest in BioVie Inc. (NASDAQ:BIVI) Decreases By 51.0% - MarketBeat
BioVie Inc. Announces Pricing of Registered Direct Offering and Concurrent Private Placement Carson City, Nevada, October 23, 2024 — BioVie Inc. (NASDAQ: BIVI), a clinical-stage company focused on developing innovative drug therapies for ch - Defense World
BioVie Raises $6 Million in Strategic Funding - TipRanks
BioVie Inc. Announces Closing of Registered Direct Offering and Concurrent Private Placement - StockTitan
BioVie Announces $6 Million Stock Offering and Placement - TipRanks
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
BioVie announces $6 million stock offering and warrants By Investing.com - Investing.com Australia
BioVie announces $6 million stock offering and warrants - Investing.com India
BioVie Inc. Announces Pricing of Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules - The Manila Times
BioVie 2.667M share registered direct offering priced at $2.25 - TipRanks
BioVie Inc. Announces Pricing of Registered Direct Offering - GlobeNewswire
BioVie stock dips after pricing offering to raise $6.66M - MSN
BioVie Announces Stock Offering and Private Placement - Yahoo Finance
Join BioVie's Exclusive Live Investor Webinar and Q&A Session on November 7th, 2024 - The Manila Times
Join BioVie’s Exclusive Live Investor Webinar and Q&A Session on November 7th, 2024 - GlobeNewswire
BioVie announces $6.7 million direct stock offering - Investing.com India
BioVie Secures $6.66 Million Through Direct Offering - TipRanks
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
3 Penny Stocks to Watch Now, 10/22/24 - TipRanks
BioVie stock dips after pricing offering to raise $6.66M (NASDAQ:BIVI) - Seeking Alpha
BioVie announces $6.7 million direct stock offering By Investing.com - Investing.com Australia
1.35%
0.87%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):